On Thursday, Uganda confirmed an outbreak of the Ebola virus in its capital city Kampala, with the first confirmed patient dying from it a day before. As per the new developments, the officials are now preparing to deploy a trial vaccine to put an end to this outbreak.
Groups of scientists are working on the vaccine and deployment of more than 2,000 doses of a candidate vaccine against the Sudan strain of Ebola has been planned and confirmed by the Uganda Virus Research Institute. As per the World Health Organization (WHO), Uganda has access to 2,169 doses of trial vaccine. For now, however, there are no approved vaccines for the strain and officials are still investigating the source of the outbreak.
The WHO had also allocated $1 million from its contingency fund for emergencies to support quick action and contain the outbreak in the country.
On Wednesday, the Sudan strain of Ebola killed a nurse employed at Kampala's main referral hospital. It is after his death that Ebola was declared an outbreak in the country. Post-mortem samples too have confirmed the Sudan Ebola Virus Disease and at least 44 contacts of the deceased man have been listed for tracing. 30 of these are health workers.
Ebola is a highly infectious hemorrhagic fever, which is transmitted through contact with bodily fluids and tissue. Symptoms include headache, vomiting of blood, muscle pains and bleeding.
it was in the late 2022, when Uganda had last suffered an Ebola outbreak. It killed 55 of the 143 people who were infected and was declared over on January 11, 2023.
As per the WHO, Ebola virus disease (EVD) is a rare but severe illness in humans and is often fatal. People can get infected with the virus if they touch an infected animal when preparing food, or touch body fluids of an infected person such as saliva, urine, faeces or semen, or things that have body fluids of an infected person like clothes or sheets.
Ebola enters the body through cuts in the skin or when one is touching their eyes, nose or mouth. Early symptoms include fever, fatigue and headache.
It was first discovered in 1976 in two simultaneous outbreak, when in Nzara, South Sudan and other in Yambuku, Democratic Republic of Congo. The latter occurred near a village near the Ebola River, which is where it gets its name from.
It is highly infectious and transmissible disease, in fact, there have been cases of health-care workers who have frequently been infected while treating patients with suspected or confirmed Ebola. This occurs through close contact with patients when infection control precautions are not practiced strictly.
Cases of people conducted burial ceremonies, involving direct contact with the body of the deceased too can lead to the transmission of Ebola. Even after the long suffering and recovery, there is a possibility of sexual transmission. Pregnant women who get acute Ebola and recover may still carry the virus in their breastmilk, or in pregnancy related fluids and tissues.
Credit: Canva
In a significant move for public health, Telangana has declared cancer as a notifiable disease and launched a cancer registry.
The state reports about 55,000 to 60,000 new cancer cases every year.
A cancer registry would help the government in having accurate data for preparing better plans to deal with the spread of cancer, said the state Health Minister C Damodar Rajanarasimha.
He noted that the state government has expanded healthcare to treat cancer by establishing Day Care Cancer Centers in district headquarters towns. Further, the government is conducting health checks for 46 lakh members of women self-help groups (SHGs).
In addition, the government would also start Regional Cancer Centers and take measures to detect diseases like cancer through AI.
A notifiable disease means that it is required by law to be reported to government authorities. The mandatory reporting facilitates surveillance, helps control.
Cancer is not currently a centrally mandated notifiable disease across all of India, as the central government focuses on surveillance through the National Cancer Registry Programme (NCRP). The NCRP was established in 1981 under the Indian Council of Medical Research (ICMR).
However, over 17 states and UTs in India have declared cancer a notifiable disease to improve data, registry accuracy, and early detection.
Also read: Cancer Is The 10th Leading Cause Of Death In Indian Children: Study
India operates two primary types of cancer registries to monitor the disease burden:
“Cancer is emerging as a major public health problem in India. There is a need to collect accurate and robust data on cancer for planning optimal cancer care services across the country,” Dr (Prof) SVS Deo, Chairman – Surgical Oncology, Max Super Speciality Hospital, Saket, told HealthandMe.
Dr. Raghav Kesri, Senior Consultant & HOD, Medical Oncology, Yatharth Hospital, Greater Noida, said that cancer registration is significant in determining the types of cancers that are most common in a certain region.
It also allows us to pinpoint the risk factors that might contribute to the increasing number of cancer cases. In India, there are cancer registrations conducted by individual states and the country as a whole.
“These statistics allow us to analyze the trend when coupled with demographics, giving us important information to consider. This is critical knowledge to ensure that we go in the right direction in our health policies, including cancer prevention, early detection, and treatment,” Kesri told HealthandMe.
Also read: Are Young Indians At Risk? The Rising Burden Of Early-Onset Cancers
Approximately 60 percent of cancers in India are preventable, including tobacco-related (lung and head and neck cancers), infection-related (stomach, liver, and cervical cancer), and lifestyle-related cancers (breast and colorectal cancers).
Common ways to prevent cancer include:
Credit: Canva
Another alarming study has highlighted the growing risk of drug resistance, this time in pathogens responsible for eye infections.
A team of Indian researchers has detected multidrug-resistant bacteria in more than 45 per cent of isolates from patients with eye infections.
The study, jointly led by CSIR-Centre for Cellular and Molecular Biology (CCMB) and LV Prasad Eye Institute (LVPEI), also reported widespread resistance to fluoroquinolones — one of the main classes of antibiotics — across all pathogens examined.
Further, the team found samples with vancomycin-resistant Staphylococcus aureus and extensively drug-resistant (XDR) Klebsiella pneumoniae strains involved in eye infections.
"These findings are worrying because they can spread their AMR genes to other bacteria, too. Also, these pathogens can infect other parts of our bodies," said Karthik Bharadwaj from CCMB.
The study, published in 'Communications Biology', raise concerns over current treatment approaches in ophthalmic care.
Researchers described the work as one of the most comprehensive genomic analyses of eye pathogens from India to date. CCMB handled genomic and bioinformatics analysis, LVPEI contributed clinical expertise, patient samples, and microbiological characterization, PTI reported.
Whole-genome sequencing helped identify new resistance mechanisms and mutations, offering deeper insight into how these pathogens evolve and spread.
Researchers said the high prevalence of resistance makes such an approach increasingly unreliable.
Also read: Gender-based Violence Surging Global Antimicrobial Resistance, Say Experts
The study underscores the need for microbiology-guided diagnosis and treatment, particularly in severe infections such as microbial keratitis and endophthalmitis.
"While genomic tools are not yet part of routine clinical workflows, the insights generated through this study provide a critical foundation for developing region-specific treatment guidelines and strengthening antimicrobial stewardship efforts in ophthalmology," said Dr Joveeta Joseph, head of microbiology at LVPEI.
Researchers also stressed that eye infections should not be viewed in isolation. The microbes involved often originate from the skin or environment, linking ophthalmic infections to the broader AMR burden.
"This study positions the eye as a valuable site for AMR surveillance in the environment around us," said Dr Prashant Garg, executive chair, LVPEI.
A recent Lancet Study reported that drug resistance is driving severe typhoid disease, hospitalization, and death among children under-5s in India.
Another 2024 Indian Council of Medical Research (ICMR)-led study also revealed a significant increase in antibiotic resistance and a decrease in the effectiveness of key antibiotics. This indicates a growing public health threat that requires immediate attention.
It showed E. coli, a common bacterium found in both ICU and outpatient settings, demonstrated a concerning rise in resistance to antibiotics like cefotaxime, ceftazidime, ciprofloxacin, and levofloxacin.
Also read: Study Links Widespread Use of Antibiotics During COVID To Surge In AMR Cases
Antimicrobial resistance (AMR) occurs when germs develop the ability to defeat the drugs designed to kill them.
It is one of the 10 top global health threats, undermining the effectiveness of essential treatments and placing millions at risk of untreatable infections.
As per WHO data, AMR is an urgent global public health threat, killing at least 1.27 million people worldwide and associated with nearly 5 million deaths in 2019.
The WHO, in a 2025 report, noted that one in six laboratory-confirmed bacterial infections causing common infections in people worldwide in 2023 were resistant to antibiotic treatments.
Credit: Canva
Panic has gripped the residents of two villages in Rajasthan's Salumbar district, where five children have reportedly died within five days. The reason: an unknown disease characterized by a sudden onset of fever that worsens rapidly, and claims the lives of children within 24 hours.
According to officials, the children who died were between 2 and 4 years old, and all of them developed high fever, convulsions, and vomiting before their condition worsened rapidly.
Besides the five children who died, another 8 children are reportedly showing similar symptoms of the unknown disease.
The incident has been reported from Ghata and Lalpura villages in Lasadiya block.
The deaths have created fear among villagers, who submitted a memorandum to the SDM and health officials, seeking immediate action and identification of the disease.
District officials, along with a medical team, have reached the villages. The District Collector has ordered an inquiry. Medical teams are currently stationed in the villages, according to local media reports. Blood samples and other tests are being conducted to check for viral infection, brain fever, or any seasonal illness.
After preliminary treatment, five of the eight children newly affected with the mystery illness were referred from Lasadiya CHC to Udaipur District Hospital. Meanwhile, three children were referred to Salumbar District Hospital.
"Seventeen teams have been deployed in Lalpura and Ghata villages. Around 562 families live in this area," said Dr. Dinesh Rai Sapela, Additional District Collector.
Health teams are also conducting door-to-door screening, as well as collecting blood samples. These samples have been sent to RNT Medical College in Udaipur for testing.
“The exact cause behind the deaths is not yet known. It could be a viral infection or a seasonal disease, but confirmation will only come after test results,” said BCMO Dr Sintu Kumawat.
Meanwhile, Gayatri Rathore, Principal Secretary of the Medical and Health Department, stated that the Chief Medical and Health Officer of the Salumbar district has been instructed to form teams of health workers to ensure intensive screening of children exhibiting fever symptoms—not only in the affected villages but also throughout Salumbar and its surrounding regions, media reports said.
“Immediate treatment will be provided to any child showing symptoms. Critically ill children are to be referred without delay to district hospitals or medical college facilities,” Rathore said.
Authorities have also initiated preventive measures against possible mosquito-borne diseases, including anti-larval activities, source reduction, and fogging operations in the affected areas.
© 2024 Bennett, Coleman & Company Limited